With New Ships, Ports, Destinations and Cruises in All Price Categories, CLIA Member Lines Poised to Offer Unique Value FORT LAUDERDALE, Fla., Jan.

Sequenom, Inc. (NASDAQ:SQNM), a leading provider of molecular diagnostic applications and genetic analysis products and services, today reported financial results for the three and nine months ended September 30, 2008.

Sequenom (NASDAQ:SQNM) today announced that it entered into an agreement to acquire the Center for Molecular Medicine (CMM), a Clinical Laboratory Improvement Act (CLIA) certified clinical diagnostics laboratory based in Grand Rapids, Michigan.

REHOVOT, Israel and JERSEY CITY, New Jersey, August 19 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. , a leading developer of microRNA-based diagnostic and therapeutic products, reported today its consolidated financial results for the quarter ended June 30, 2008 and business highlights.